News

Creating a Promising and Novel Molecule In their research, Professor Gauthier's team studied two natural molecules: betulinic ...
There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...
So despite the success of HIV drugs and PrEP, precarious health-care systems and high drug costs mean we can't rely on them ...
When it comes to a clinical study to evaluate the therapeutic effect of Shivagutika treatment in patients with HIV, it was ...
Current tuberculosis infection tests struggle to detect the disease in those with HIV. A common co-infection, HIV can hide TB ...
A new credit card-sized tuberculosis (TB) test, requiring no electricity, could revolutionize detection in HIV hotspots by ...
Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing ...
Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...
HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.
HIV remains incurable but manageable. Johns Hopkins found a way to silence it long-term using a molecule from the virus ...
A new nanozyme-powered TB test improves detection in people with HIV, offering rapid, electricity-free diagnosis via a beetle-inspired chip.
A panelist discusses how squamous cell cancer of the anal canal has nearly doubled in incidence over 30 years, with human ...